NO980095D0 - Nye quinoxalin- og quinoxalinylalkan-forfonsyrer - Google Patents

Nye quinoxalin- og quinoxalinylalkan-forfonsyrer

Info

Publication number
NO980095D0
NO980095D0 NO980095A NO980095A NO980095D0 NO 980095 D0 NO980095 D0 NO 980095D0 NO 980095 A NO980095 A NO 980095A NO 980095 A NO980095 A NO 980095A NO 980095 D0 NO980095 D0 NO 980095D0
Authority
NO
Norway
Prior art keywords
quinoxalinyl
alkane
phonic acids
new quinoxaline
quinoxaline
Prior art date
Application number
NO980095A
Other languages
English (en)
Other versions
NO980095L (no
Inventor
Robert Moretti
Hans Allgeier
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO980095D0 publication Critical patent/NO980095D0/no
Publication of NO980095L publication Critical patent/NO980095L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
NO980095A 1995-07-10 1998-01-09 Nye quinoxalin- og quinoxalinylalkan-forfonsyrer NO980095L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH200995 1995-07-10
PCT/EP1996/002866 WO1997003079A1 (en) 1995-07-10 1996-07-01 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids

Publications (2)

Publication Number Publication Date
NO980095D0 true NO980095D0 (no) 1998-01-09
NO980095L NO980095L (no) 1998-03-05

Family

ID=4223780

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980095A NO980095L (no) 1995-07-10 1998-01-09 Nye quinoxalin- og quinoxalinylalkan-forfonsyrer

Country Status (15)

Country Link
EP (1) EP0837864A1 (no)
JP (1) JPH11508902A (no)
KR (1) KR19990028839A (no)
AU (1) AU6516296A (no)
BR (1) BR9609644A (no)
CA (1) CA2224718A1 (no)
CZ (1) CZ5398A3 (no)
HU (1) HUP9901345A3 (no)
IL (1) IL122872A0 (no)
NO (1) NO980095L (no)
PL (1) PL324340A1 (no)
SK (1) SK2798A3 (no)
TR (1) TR199800022T1 (no)
WO (1) WO1997003079A1 (no)
ZA (1) ZA965800B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21927A (id) * 1996-10-24 1999-08-12 Novartis Ag Asam aminoalkanafosfonat tersubstitusi
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118675A (en) * 1991-02-15 1992-06-02 American Home Products Corporation Quinoxaline phosphono-amino acids
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CA2224718A1 (en) 1997-01-30
NO980095L (no) 1998-03-05
SK2798A3 (en) 1998-07-08
TR199800022T1 (xx) 1998-05-21
WO1997003079A1 (en) 1997-01-30
MX9800332A (es) 1998-07-31
HUP9901345A3 (en) 2000-01-28
KR19990028839A (ko) 1999-04-15
JPH11508902A (ja) 1999-08-03
BR9609644A (pt) 1999-05-11
PL324340A1 (en) 1998-05-25
EP0837864A1 (en) 1998-04-29
CZ5398A3 (cs) 1998-06-17
HUP9901345A2 (hu) 1999-08-30
AU6516296A (en) 1997-02-10
ZA965800B (en) 1997-01-10
IL122872A0 (en) 1998-08-16

Similar Documents

Publication Publication Date Title
KR970707184A (ko) 장쇄 분지형 중합체 및 이들의 제조방법(long-chain branched polymers and their production)
NO973231D0 (no) Nye forbindelser
NO960472D0 (no) Nye forbindelser
DE69522152T2 (de) Stimmen verfolgendes Videosystem
NO970512D0 (no) Nye heteroaryl-oksazolidinoner
ID19227A (id) Metoda memproduksi asam-asam karboksilat
NO964095D0 (no) Nye hydroksypyridinoner
DE69521230D1 (de) Herstellung von alpha-beta-ungesättigten C3-C6-Carbonsäuren
TR199500793A2 (tr) Sülfitlerin oksitlenmesini kontrol etme metodu.
DK0906288T3 (da) Nye forbindelser
DK0724106T3 (da) Spændering
DE69804513T2 (de) Herstellung von zeolith-l
DE69609706D1 (de) Kompatibilisierungssystem von unvermischbaren polymeren
BR9510426A (pt) Produção de cefotaxima
NO980095D0 (no) Nye quinoxalin- og quinoxalinylalkan-forfonsyrer
NO971711L (no) Nye retinoider
BR9407997A (pt) Polímero radial assimétrico
DE59603127D1 (de) Radiallager
ID20291A (id) Asam-asam oksobutirat tersubstitusi sebagai penghamba-penghambat matriks metaloproteasa
DE69705849T2 (de) Herstellung von 3,5-lutidin
DE69702961T2 (de) Herstellung von 1,1-difluorethan
NO990072D0 (no) Nye forbindelser
DE69619812T2 (de) Kontinuierliche herstellung von 1,1-difluorethan
IT1281419B1 (it) Cesoia ad inseguimento
KR970001381A (ko) 중합체의 회수 방법